Navigation Links
Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C
Date:11/2/2009

al hazard to a fetus. A Ribavirin Pregnancy Registry has been established to monitor maternal-fetal outcomes of pregnancies in female patients and female partners of male patients exposed to ribavirin during treatment, and for six months following cessation of treatment. Physicians and patients are encouraged to report such cases by calling 1-800-593-2214.

Incidence of Adverse Events

Most common adverse reactions ( > 40%) in adult patients receiving either PEGINTRON or PEGINTRON/REBETOL are injection site inflammation/reaction, fatigue/asthenia, headache, rigors, fevers, nausea, myalgia, and anxiety/emotional lability/irritability. Most common adverse reactions ( > 25%) in pediatric patients receiving PEGINTRON/REBETOL are pyrexia, headache, neutropenia, fatigue, anorexia, injection site erythema, and vomiting.

In a study with PEGINTRON/REBETOL (weight-based) combination therapy in adult patients, anemia with weight-based dosing was 29%; however, the majority of these cases were mild and responded to dose reductions. The incidence of serious adverse reactions reported for the weight-based REBETOL group was 12%. In many but not all cases, adverse reactions resolved after dose reduction or discontinuation of therapy. Some patients experienced ongoing or new serious adverse reactions during the 6-month follow-up period. Discontinuations for adverse events were 15% and were related to known interferon effects of psychiatric, systemic (e.g., fatigue, headache), or gastrointestinal adverse reactions. Dose modifications due to adverse reactions occurred in 29% of patients.

Most common adverse reactions with PEGINTRON/REBETOL (weight-based) combination therapy were psychiatric, which occurred among 68-69% of patients. These psychiatric adverse reactions included most commonly depression, irritability, and insomnia, each reported by approximately 30-40% of subjects in all treatment groups. Suicidal behavior (ideati
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
2. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
3. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
4. Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA
5. Schering-Plough Reports Top-Line Results of the IDEAL Study
6. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
7. Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients
8. Schering-Plough Announces Imperfect Contraceptive Use Impacts Womens Emotional Well-Being
9. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
10. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
11. Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... TAIPEI , May 4, 2015 ... partner, Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) ... BAX ) jointly announced that Baxter has ... European Medicines Agency (EMA) for MM-398 (irinotecan liposome ... metastatic adenocarcinoma of the pancreas who have been ...
(Date:5/4/2015)...  Makindus, Inc. a specialty pharmaceutical development company focused ... (EMA) has granted orphan drug designation for their lead ... "We are extremely pleased to now have orphan ... place for Europe . This complements ... United States for which orphan designation has ...
(Date:5/4/2015)... Bayer HealthCare (Bayer) has entered into an ... ISIS ) on ISIS-FXI Rx, an antisense investigational ... Under the agreement Bayer will further develop and commercialize ... need. As part of the clinical development program, Bayer ... in an appropriate patient community. "Bayer ...
Breaking Medicine Technology:PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 3European Medicines Agency (EMA) Grants Orphan Designation for Makindus' MI-100 for Stargardt's Disease 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 3
... TechPrecision Corporation (OTC Bulletin Board: ... manufacturer of large-scale, high-precision metal machining fabrications and ... nuclear, defense, aerospace and other commercial industries, today ... purchase order valued at approximately $450,000.  The order, ...
... Inc. today announced that it has expanded its ... gene, CYP2C9, to further support clinicians in prescribing medications ... of the CYP2C9 gene, variations of which can cause ... psychotropic medications, provides physicians with further information on gene ...
Cached Medicine Technology:TechPrecision Corporation Receives New $450,000 Medical Purchase Order 2AssureRx Expands GeneSightRx® Pharmacogenetic Profile with Sixth Gene to Enhance Guidance of Psychiatric Drug Prescribing 2AssureRx Expands GeneSightRx® Pharmacogenetic Profile with Sixth Gene to Enhance Guidance of Psychiatric Drug Prescribing 3
(Date:5/4/2015)... The National Association of Professional Women ... 2015-2016 inductee into the NAPW VIP Woman of the ... for leadership in oral healthcare. NAPW is the nation's ... than 700,000 members and over 200 operating Local Chapters. ... group of professional women," said NAPW President Star Jones. ...
(Date:5/4/2015)... Montreal, CANADA (PRWEB) May 04, 2015 ... development of innovative proofreading technologies, today announced that ... #438 at the Music City Center, in Nashville ... Proofware is the world's first true all-in-one we-based ... everyone involved in the security of their brand ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 The ... Group today launched a new initiative at UC ... next generation of physicians committed to advancing Latino ... Ser Medicos, or Preparing Students to Be Physicians, ... that will provide scholarships, mentorship and internship opportunities, ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Getting patients ... manage their health is critical to achieving the “triple ... reducing costs, but this will require a shift in ... also demands that health systems move beyond their traditional ... took part in the third live meeting of the ...
(Date:5/4/2015)... 04, 2015 The American Telemedicine Association ... policy reports which identify gaps in coverage and reimbursement, ... issued the State Telemedicine Gaps Reports last September, many ... laws and regulations impact healthcare delivery in their state,” ... of state actions across the nation, ATA reevaluated the ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Elizabeth Moncada, Owner, Moncada Center for Orofacial Pain, into its 2015-2016 VIP Woman of the Year Circle 2Health News:Global Vision to Spotlight Proofware at INFO*FLEX 2015 2Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 2Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 3Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 4Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 5Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 2Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 3Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 4Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 2Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 3
... Nielsen Company , a leading global information and media company ... advertising and design competitions, announced today that the first-ever ... at www.CLIOHealthcare.com . The submission deadline is August ... June 30, 2009. , , "We are looking forward to ...
... psychiatrists and psychologists from The Child Study Center at NYU ... parents face today , , Expert advice and tips ... disorders, depression, anxiety, homosexuality and more explored on marathon of Doctor ... 1 SIRIUS XM Radio (Nasdaq: SIRI ) today ...
... pilot prevention program targeting fifth graders and their younger ... on Drug Abuse as part of the National Institutes ... award is for two years. The program aims ... and thereby decrease risky behavior and use of drugs ...
... determined that movie characters who smoke, regardless of whether they ... smoking. The study, published in the July 2009 issue of ... Matters More, Good Guys or Bad Guys?" "Previous studies ... initiation of smoking by adolescents, and we wanted to dig ...
... for Dedication to Improving Animal Health and Well-Being , ... for the third annual Thank Your Vet for a ... The national short-essay contest honors America,s veterinarians for their ... have with our pets. The nationwide essay contest runs ...
... National Alliance on Mental Illness (NAMI) reminds Americans that July ... a time for public education about serious mental illness in ... House of Representatives designated July as Bebe Moore Campbell National ... African American novelist and journalist, who also was a voice ...
Cached Medicine News:Health News:Nielsen Announces First-Ever CLIO Healthcare Awards Now Accepting Entries 2Health News:Nielsen Announces First-Ever CLIO Healthcare Awards Now Accepting Entries 3Health News:SIRIUS XM's Doctor Radio to Air July 4th Family Special '24 Hours About Our Kids: Why Kids Behave the Way They Do' 2Health News:SIRIUS XM's Doctor Radio to Air July 4th Family Special '24 Hours About Our Kids: Why Kids Behave the Way They Do' 3Health News:SIRIUS XM's Doctor Radio to Air July 4th Family Special '24 Hours About Our Kids: Why Kids Behave the Way They Do' 4Health News:SIRIUS XM's Doctor Radio to Air July 4th Family Special '24 Hours About Our Kids: Why Kids Behave the Way They Do' 5Health News:SIRIUS XM's Doctor Radio to Air July 4th Family Special '24 Hours About Our Kids: Why Kids Behave the Way They Do' 6Health News:Both good/bad movie characters who smoke influence teens to do the same 2Health News:Search for America's Best Veterinarian Continues With Third Annual 'Thank Your Vet for a Healthy Pet(R)' Contest 2Health News:NAMI Observes Minority Mental Health Awareness Month 2
PVC Sealing Tape, 100/Box...
Mylar Plate Sealers 100/Box...
OptiTape - Optically Clear sealing tape for OmniUltra PCR plates. 250 sheet roll....
TDX Tape - sealing sheets for polypropylene plates only, 100/PK...
Medicine Products: